In our cross-sectional analysis of CPHIV who did or did not meet clinical definitions of “possible” mitochondrial disease, we found significantly higher plasma levels of the mitokines FGF21 and/or GDF15 in those with MDC score ≥3. The gene discussed is FGF21; the disease is inborn mitochondrial metabolism disorder.